Glaxosmithkline Share News (GSK)

Glaxosmithkline Information

Buy GSK Shares
Add GSK to Watchlist
Add GSK to Alert

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 1,799.50

Bid: 1,796.00

Ask: 1,796.50

Change: 19.00 (1.07%)

Spread: 0.50 (0.028%)

Open: 1,784.00

High: 1,799.50

Low: 1,780.00

Prev. Close: 1,780.50

Last checked at -

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

Mon, 27th Feb 2023 09:26

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

----------

FTSE 100

----------

SocGen raises Rolls-Royce price target to 148 pence - 'hold'

----------

Bank of America raises Rolls-Royce to 'buy' (underperform) - price target 175 (97) pence

----------

Jefferies raises Rolls-Royce price target to 170 (125) pence - 'buy'

----------

Jefferies raises BAE Systems price target to 1,060 (1,000) pence - 'buy'

----------

SocGen raises BAE Systems price target to 1,086 pence - 'buy'

----------

Bank of America raises International Consolidated Airlines price target to 240 (200) pence - 'buy'

----------

Barclays raises International Consolidated Airlines price target to 165 (160) pence - 'equal weight'

----------

Bernstein raises International Consolidated Airlines price target to 190 (180) pence - 'outperform'

----------

Goldman Sachs raises BP price target to 740 (690) pence - 'conviction buy list'

----------

Goldman Sachs raises Shell to 'buy' (neutral) - price target 40 (35) EUR

----------

Goldman Sachs raises Vodafone price target to 130 (120) pence - 'buy'

----------

Jefferies cuts Mondi price target to 1,710 (1,730) pence - 'buy'

----------

Jefferies cuts British American Tobacco price target to 4,100 (4,700) pence - 'buy'

----------

Jefferies cuts Imperial Brands price target to 1,993 (2,007) pence - 'hold'

----------

HSBC raises Rightmove to 'hold' - price target 530 pence

----------

Barclays cuts Anglo American price target to 2,900 (3,250) pence - 'equal weight'

----------

Goldman Sachs reinitiates GSK with 'buy' - price target 2,000 pence

----------

Citigroup cuts Hargreaves Lansdown to 'sell' - price target 730 pence

----------

JPMorgan raises Lloyds price target to 61 (58) pence - 'neutral'

----------

JPMorgan raises NatWest price target to 340 (330) pence - 'neutral'

----------

JPMorgan raises Barclays price target to 240 (230) pence - 'overweight'

----------

Deutsche Bank raises Standard Chartered price target to 890 (800) pence - 'hold'

----------

Barclays raises Prudential price target to 1,750 (1,518) pence - 'overweight'

----------

FTSE 250

----------

Citigroup cuts Quilter to 'sell' - price target 75 pence

----------

Berenberg raises Hikma Pharmaceutical target to 1,740 (1,440) pence - 'hold'

----------

Barclays raises Jupiter Fund price target to 130 (120) pence - 'equal weight'

----------

Peel Hunt cuts Howden Joinery Group to 'add' (buy) - price target 770 (700) pence

----------

Deutsche Bank raises Trainline to 'buy' (hold) - price target 287 (350) pence

----------

Jefferies raises Senior price target to 195 (180) pence - 'buy'

----------

SMALL CAP

----------

Berenberg cuts Resolute Mining price target to 24 (25) pence - 'buy'

----------

Jefferies raises Conduit Holdings price target to 650 (620) pence - 'buy'

----------

More News

17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Latest Share Chat

Glaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

Login to your account

Quickpicks are a member only feature

Login to your account